Before Invest
Merck & Co., Inc. logo

Merck & Co., Inc.

MRK
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 40 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jun 30, 2012Mar 31, 2012Sep 30, 2011Jun 30, 2011Mar 31, 2011Sep 30, 2010Jun 30, 2010Mar 31, 2010Sep 30, 2009Jun 30, 2009
Current Assets
                                                    
Cash and cash equivalents
$ 6,849
$ 5,327
$ 18,169
$ 8,007
$ 8,629
$ 14,593
$ 11,304
$ 5,579
$ 8,605
$ 5,660
$ 9,707
$ 11,145
Short-term investments
292
375
45
615
599
0
50
40
168
718
680
103
Accounts receivable (net of allowance for doubtful accounts of $108 in 2026 and $97 in 2025)
12,564
12,210
12,120
11,846
10,790
11,381
11,642
11,366
10,394
11,030
10,415
9,482
Inventories (excludes inventories of $6,381 in 2026 and $5,681 in 2025 classified in Other assets - see Note 6)
6,207
6,479
6,444
6,601
6,196
6,244
6,469
6,510
6,131
5,930
5,863
5,614
Other current assets
10,767
10,624
10,779
9,996
9,289
8,143
8,740
7,950
6,656
6,639
6,737
7,217
Current assets of discontinued operations
-
-
-
-
-
-
-
-
-
-
-
-
Deferred income taxes
-
-
-
-
-
-
-
-
-
-
-
-
Prepaid expenses and other current assets
-
-
-
-
-
-
-
-
-
-
-
-
Total current assets
36,679
35,015
47,557
37,065
35,503
40,361
38,205
31,445
31,954
29,977
33,402
33,561
Investments
1,222
1,105
1,117
774
616
575
357
280
1,306
1,214
1,290
984
Property, plant and equipment
-
-
-
-
-
-
-
-
-
-
-
-
Less accumulated depreciation
-
-
-
-
-
-
-
-
-
-
-
-
Property, Plant and Equipment, at cost, net of accumulated depreciation of $22,729 in 2026 and $21,914 in 2025
25,737
25,433
25,639
25,236
24,793
23,446
23,221
23,045
22,526
22,231
21,758
20,424
Goodwill
21,582
21,581
21,587
21,591
21,684
21,697
21,161
21,181
21,183
21,195
21,209
21,160
Other Intangibles, Net
24,978
25,745
15,313
15,193
15,758
17,010
16,984
17,572
19,199
19,665
19,857
21,368
Other intangible assets, net
-
-
-
-
-
-
-
-
-
-
-
-
Other Assets
19,604
19,806
18,333
17,664
16,768
14,443
12,702
12,326
10,559
10,187
10,280
9,584
Noncurrent Assets of Discontinued Operations
-
-
-
-
-
-
-
-
-
-
-
-
Total Assets
129,802
128,685
129,546
117,523
115,122
117,532
112,630
105,849
106,727
104,469
107,796
107,081
Liabilities and Equity
                                                    
Current Liabilities
                                                    
Loans payable and current portion of long-term debt
2,825
2,444
1,405
1,434
1,360
3,149
3,071
3,077
887
2,839
2,672
1,936
Trade accounts payable
3,827
3,863
4,147
3,892
3,784
3,586
3,519
3,514
3,509
3,442
3,680
3,371
Accrued compensation
-
-
-
-
-
-
-
-
-
-
-
-
Accrued and other current liabilities
14,725
14,549
16,186
14,502
12,772
16,539
14,712
14,102
14,840
13,747
13,000
14,222
Income taxes payable
4,224
3,946
4,848
4,156
5,181
4,330
2,777
2,398
1,981
1,489
1,872
1,698
Dividends payable
2,130
2,143
2,042
2,053
2,077
1,982
1,981
2,008
1,877
1,877
1,907
1,771
Current liabilities of discontinued operations
-
-
-
-
-
-
-
-
-
-
-
-
6% Mandatory convertible preferred stock, $1 par value Authorized - 11,500,000 shares Issued and outstanding - 855,422 shares in 2009
-
-
-
-
-
-
-
-
-
-
-
-
Total current liabilities
27,731
26,945
28,628
26,037
25,174
29,586
26,060
25,099
23,094
23,394
23,131
22,998
Long-term Liabilities:
                                                    
Long-Term Debt
51,081
46,673
39,969
33,968
33,484
34,982
34,717
31,142
33,972
34,072
28,074
28,482
Deferred Income Taxes
1,433
1,494
1,381
1,427
1,409
864
876
922
1,018
996
1,442
2,417
Other Noncurrent Liabilities
7,573
7,642
7,661
7,031
6,655
7,540
7,329
8,262
7,343
7,265
8,244
8,660
Noncurrent Liabilities of Discontinued Operations
-
-
-
-
-
-
-
-
-
-
-
-
Deferred Income Taxes and Noncurrent Liabilities
-
-
-
-
-
-
-
-
-
-
-
-
Total long-term liabilities
-
-
-
-
-
-
-
-
-
-
-
-
Merck & Co., Inc. Stockholders’ Equity
                                                    
2007 Mandatory convertible preferred shares - $1 par value; $250 per share face value; issued: 10 at September 30, 2009 and December 31, 2008
-
-
-
-
-
-
-
-
-
-
-
-
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2026 and 2025
1,788
1,788
1,788
1,788
1,788
1,788
1,788
1,788
1,788
1,788
1,788
1,788
Other paid-in capital
44,950
45,176
44,832
44,644
44,816
44,530
44,362
44,598
44,358
44,219
44,467
44,243
Paid-in capital
-
-
-
-
-
-
-
-
-
-
-
-
Retained earnings
63,269
66,721
72,231
68,477
66,097
61,384
60,187
56,697
57,082
54,198
62,039
59,928
Accumulated other comprehensive loss
(3,942)
(4,060)
(5,202)
(5,421)
(4,965)
(5,371)
(5,361)
(5,274)
(4,916)
(4,900)
(4,883)
(4,743)
Stockholders' equity before deduction for treasury stock
106,065
109,625
113,649
109,488
107,736
102,331
100,976
97,809
98,312
95,305
103,411
101,216
Less treasury stock, at cost: 1,108,460,187 shares in 2026 and 1,102,476,756 shares in 2025
64,132
63,747
61,799
60,495
59,401
57,829
57,394
57,445
57,066
56,612
56,577
56,758
Total
-
-
-
-
-
-
-
-
-
-
-
-
Total Merck & Co., Inc. stockholders’ equity
41,933
45,878
51,850
48,993
48,335
44,502
43,582
40,364
41,246
38,693
46,834
44,458
Noncontrolling Interests
51
53
57
67
65
58
66
60
54
49
71
66
Total equity
41,984
45,931
51,907
49,060
48,400
44,560
43,648
40,424
41,300
38,742
46,905
44,524
Liabilities and Equity
$ 129,802
$ 128,685
$ 129,546
$ 117,523
$ 115,122
$ 117,532
$ 112,630
$ 105,849
$ 106,727
$ 104,469
$ 107,796
$ 107,081